Birdwatch Note Rating
2024-05-19 07:20:59 UTC - HELPFUL
Rated by Participant: 2E51EA05C87BE1B15021814B2D246772089BD0BA03B3F166BF0CA83F432B81BE
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 50% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://nejm.org/doi/full/10.1056/nejmoa1910993 https://paho.org/en/topics/ebola-virus-disease
All Note Details